Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06487351 · ClinicalTrials.gov registry record · NA
Intervention to Reduce Implicit Bias in Pharmacies
A NA study, sponsored by Massachusetts General Hospital.
- Not yet
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT06487351: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT06487351 is a NA study that has not yet begun recruiting, run by Massachusetts General Hospital. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06487351, a NA study, has not yet begun recruiting, sponsored by Massachusetts General Hospital.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
This study will follow the ADAPT-ITT model to apply the Prejudice Habit Breaking Intervention (PHBI) to pharmacists who have experience with or are willing to prescribe PrEP. We will first collect qualitative data through focus group discussions guided by the Health Equity Implementation Framework (HEIF) on determinants related to the intervention itself, pharmacists, and the community pharmacy context that may impact implementation of the PHBI. Then, we will use this information to adapt the PHBI in an iterative process involving topic experts, pharmacists, and PrEP users. We will then determine the feasibility, acceptability, and preliminary impact of the adapted PHBI to reduce implicit racial bias.
Interventions
- BEHAVIORAL The adapted PHBI
- BEHAVIORAL The NIH Implicit Bias course
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2027-07 |
| Est. Completion | 2029-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06487351
The ClinicalTrials.gov registry entry for NCT06487351 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which The adapted PHBI is the first listed.
NCT06487351 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06487351 about?
NCT06487351 is a clinical study titled "Intervention to Reduce Implicit Bias in Pharmacies". This study will follow the ADAPT-ITT model to apply the Prejudice Habit Breaking Intervention (PHBI) to pharmacists who have experience with or are willing to prescribe PrEP. We will first collect qualitative data through focus group discussions guided by the Health Equity Implementation Framework (...
What is the current status of trial NCT06487351?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2027-07. Estimated completion is 2029-07.
What interventions are being tested in trial NCT06487351?
The interventions under investigation include: The adapted PHBI (BEHAVIORAL), The NIH Implicit Bias course (BEHAVIORAL).
Who is sponsoring clinical trial NCT06487351?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.